Thieno[3,2-d]pyrimidines derivatives for the treatment of viral infections
US-9556199-B2 · Jan 31, 2017 · US
Purine derivatives for the treatment of viral infections
US10280167B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10280167-B2 |
| Application number | US-201715420045-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 30, 2017 |
| Priority date | Nov 9, 2011 |
| Publication date | May 7, 2019 |
| Grant date | May 7, 2019 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to purine derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for activating TLR7 in a subject comprising administering to said subject an effective amount of a compound selected from the group consisting of wherein said subject is treated for a viral infection. 2. A method for inducing interferon production in a subject, comprising administering to said subject an effective amount of a compound selected from the group consisting of wherein said subject is treated for a viral infection. 3. A method of activating TLR7 in a subject treated for a viral infection comprising administering to said subject a pharmaceutical compositions comprising a compound selected from the group consisting of and one or more pharmaceutically acceptable excipients, diluents or carriers. 4. A method of inducing interferon production in a subject treated for a viral infection comprising administering to said subject a pharmaceutical composition comprising a compound selected from the group consisting of and one or more pharmaceutically acceptable excipients, diluents or carriers.
Assignees
Inventors
Classifications
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Immunomodulators · CPC title
Drugs for immunological or allergic disorders · CPC title
Antivirals · CPC title
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10280167B2 cover?
- The present invention relates to purine derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections.
- Who is the assignee on this patent?
- Janssen Sciences Ireland Uc
- What technology area does this patent fall under?
- Primary CPC classification C07D473/16. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).